GetTopicDetailResponse(id=ef9a191128c, topicName=Zynteglo, introduction=Zynteglo, content=null, image=null, comments=4, allHits=1272, url=https://h5.medsci.cn/topic?id=19112, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=88301, tagList=[TagDto(tagId=88301, tagName=Zynteglo)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1720689, encodeId=02211e2068999, content=<a href='/topic/show?id=ef9a191128c' target=_blank style='color:#2F92EE;'>#Zynteglo#</a>, objectTitle=藍(lán)鳥(niǎo)生物宣布在德國(guó)推出一次性的基因療法ZYNTEGLO（編碼βA-T87Q-globin基因的自體CD34 +細(xì)胞），用于治療輸血依賴性β-地中海貧血, objectType=article, longId=186375, objectId=80711863e538, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=80711863e538, replyNumber=0, likeNumber=83, createdTime=2020-05-16, rootId=0, userName=cooco, userId=5b2732925303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=80711863e538, moduleTitle=藍(lán)鳥(niǎo)生物宣布在德國(guó)推出一次性的基因療法ZYNTEGLO（編碼βA-T87Q-globin基因的自體CD34 +細(xì)胞），用于治療輸血依賴性β-地中海貧血, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=80711863e538)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720688, encodeId=01881e20688e4, content=<a href='/topic/show?id=ef9a191128c' target=_blank style='color:#2F92EE;'>#Zynteglo#</a>, objectTitle=藍(lán)鳥(niǎo)生物生產(chǎn)規(guī)范獲EMA批準(zhǔn) 基因療法Zynteglo準(zhǔn)備上市！, objectType=article, longId=181935, objectId=f4c8181935c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f4c8181935c7, replyNumber=0, likeNumber=90, createdTime=2019-11-08, rootId=0, userName=cooco, userId=5b2732925303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f4c8181935c7, moduleTitle=藍(lán)鳥(niǎo)生物生產(chǎn)規(guī)范獲EMA批準(zhǔn) 基因療法Zynteglo準(zhǔn)備上市！, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=f4c8181935c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720686, encodeId=80661e2068638, content=<a href='/topic/show?id=ef9a191128c' target=_blank style='color:#2F92EE;'>#Zynteglo#</a>, objectTitle=歐洲CHMP推薦將Bluebird公司的基因療法Zynteglo用于治療輸血依賴性β-地中海貧血, objectType=article, longId=163435, objectId=ce74163435a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce74163435a9, replyNumber=0, likeNumber=95, createdTime=2019-11-04, rootId=0, userName=cooco, userId=5b2732925303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce74163435a9, moduleTitle=歐洲CHMP推薦將Bluebird公司的基因療法Zynteglo用于治療輸血依賴性β-地中海貧血, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=ce74163435a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1720687, encodeId=72a51e2068787, content=<a href='/topic/show?id=ef9a191128c' target=_blank style='color:#2F92EE;'>#Zynteglo#</a>, objectTitle=Bluebirdβ-地中海貧血基因療法Zynteglo，喜獲歐盟有條件的上市許可, objectType=article, longId=167643, objectId=f63916e643e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f63916e643e2, replyNumber=0, likeNumber=98, createdTime=2020-02-10, rootId=0, userName=cooco, userId=5b2732925303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f63916e643e2, moduleTitle=Bluebirdβ-地中海貧血基因療法Zynteglo，喜獲歐盟有條件的上市許可, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=f63916e643e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
